May 27, 2026 08:00AM
Apr 21, 2026 08:00AM
Apr 20, 2026 08:00AM
Apr 16, 2026 08:00AM
Mar 3, 2026 08:00AM
Feb 2, 2026 09:27AM
Jan 14, 2026 08:00AM PharmaTher Expands PharmaPatch(TM) Platform into GLP-1 for Obesity, Leveraging Its Ketamine and Psychedelic Patch Programs
Jan 2, 2026 08:00AM
Dec 2, 2025 09:53AM
Nov 17, 2025 08:00AM
Oct 17, 2025 08:26AM
Oct 16, 2025 08:04AM
Oct 16, 2025 08:00AM
Oct 15, 2025 08:00AM PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings
Oct 8, 2025 08:00AM
Aug 27, 2025 08:00AM
Aug 14, 2025 08:02AM
Aug 14, 2025 08:00AM
Aug 11, 2025 09:51AM
Aug 11, 2025 09:49AM
Aug 11, 2025 09:26AM PharmaTher receives FDA approval for ketamine product KETARx
Aug 11, 2025 09:26AM
Jun 18, 2025 08:00AM
Mar 3, 2025 08:00AM
Sep 19, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 19, 2024 08:00AM
May 15, 2024 08:00AM PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
May 1, 2024 08:50AM
May 2, 2023 07:30AM
Apr 3, 2023 07:00AM
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™ (Ketamine) for the Treatment of Rett Syndrome
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM
Jan 11, 2023 08:15AM
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease
Sep 29, 2022 07:00AM
Sep 16, 2022 07:00AM
Sep 7, 2022 07:00AM
Jul 13, 2022 07:00AM
Jun 29, 2022 07:00AM
Jun 7, 2022 07:00AM
May 25, 2022 07:00AM PharmaTher To Develop and Commercialize Novel Wearable Ketamine Delivery Device in Collaboration with CCBIO
May 5, 2022 07:00AM

323,752 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All